SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19

I Vicenti, M Zazzi, F Saladini - Expert Opinion on Therapeutic …, 2021 - Taylor & Francis
ABSTRACT Introduction: The current SARS-CoV-2 pandemic urgently demands for both
prevention and treatment strategies. RNA-dependent RNA-polymerase (RdRp), which has …

Methodology-centered review of molecular modeling, simulation, and prediction of SARS-CoV-2

K Gao, R Wang, J Chen, L Cheng, J Frishcosy… - Chemical …, 2022 - ACS Publications
Despite tremendous efforts in the past two years, our understanding of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), virus–host interactions, immune …

Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective

A Alrehaily, AA Elfiky, IM Ibrahim, MN Ibrahim… - Scientific Reports, 2023 - nature.com
The human coronavirus, SARS-CoV-2, had a negative impact on both the economy and
human health, and the emerging resistant variants are an ongoing threat. One essential …

Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective

IM Ibrahim, AA Elfiky, AM Elgohary - Biochemical and Biophysical …, 2021 - Elsevier
New SARS-CoV-2 variants emerged in the United Kingdom and South Africa in December
2020 in concomitant with the Brazillian variant in February 2021 (B. 1.1. 248 lineage) and …

Application of artificial intelligence (AI) to control COVID-19 pandemic: Current status and future prospects

S Ashique, N Mishra, S Mohanto, A Garg… - Heliyon, 2024 - cell.com
The impact of the coronavirus disease 2019 (COVID-19) pandemic on the everyday
livelihood of people has been monumental and unparalleled. Although the pandemic has …

Combination Therapy of Ledipasvir and Itraconazole in the Treatment of COVID‐19 Patients Coinfected with Black Fungus: An In Silico Statement

S Saha, GS Yeom, SB Nimse… - BioMed Research …, 2022 - Wiley Online Library
The manuscript mainly aimed at providing clues on improving the innate immunity of
coronavirus patients and safeguarding them from both new mutant strains and black fungus …

Effect of sofosbuvir-based treatment on clinical outcomes of patients with COVID-19: a systematic review and meta-analysis of randomised controlled trials

CK Hsu, CY Chen, WC Chen, CC Lai, SH Hung… - International Journal of …, 2022 - Elsevier
This systematic review and meta-analysis examined the efficacy of sofosbuvir-based
antiviral treatment against COVID-19 (coronavirus disease 2019). PubMed, Embase …

[HTML][HTML] COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery

S Kumar, M Basu, P Ghosh, U Pal, MK Ghosh - Genes & Diseases, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the complicated
disease COVID-19. Clinicians are continuously facing huge problems in the treatment of …

Dual Targeting of RdRps of SARS-CoV-2 and the Mucormycosis-Causing Fungus: An in silico Perspective

AA Elfiky - Future Microbiology, 2022 - Taylor & Francis
During the past few months, mucormycosis has been associated with SARS-CoV-2
infections. Molecular docking combined with molecular dynamics simulation is utilized to test …

Molecular dynamics simulations and MM-GBSA reveal novel guanosine derivatives against SARS-CoV-2 RNA dependent RNA polymerase

AA Elfiky, HA Mahran, IM Ibrahim, MN Ibrahim… - RSC …, 2022 - pubs.rsc.org
According to the World Health Organization (WHO), SARS-CoV-2 is responsible for more
than 5 M deaths and is reported in 223 countries infecting 250+ M people. Despite the …